1. ALK‐positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature. (23rd October 2017) Authors: Geller, Shamir; Canavan, Theresa N.; Pulitzer, Melissa; Moskowitz, Alison J.; Myskowski, Patricia L. Journal: International journal of dermatology Issue: Volume 57:Number 5(2018) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Issue 20 (10th July 2021) Authors: Kumar, Anita; Casulo, Carla; Advani, Ranjana H.; Budde, Elizabeth; Barr, Paul M.; Batlevi, Connie L.; Caron, Philip; Constine, Louis S.; Dandapani, Savita V.; Drill, Esther; Drullinsky, Pamela; Friedberg, Jonathan W.; Grieve, Clare; Hamilton, Audrey; Hamlin, Paul A.; Hoppe, Richard T.; Horwitz, S... Journal: Journal of clinical oncology Issue: Volume 39:Issue 20(2021) Page Start: 2257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Issue 9 (20th June 2016) Authors: Cheah, Chan Y.; Bröckelmann, Paul J.; Chihara, Dai; Moskowitz, Alison J.; Engert, Andreas; Jerkeman, Mats; El‐Galaly, Tarec C.; Augustson, Bradley; Vose, Julie; Bartlett, Nancy L.; Villa, Diego; Connors, Joseph M.; Feldman, Tatyana; Pinnix, Chelsea C.; Milgrom, Sarah A.; Dabaja, Bouthaina; Oki, Y... Journal: American journal of hematology Issue: Volume 91:Issue 9(2016:Sep.) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma. (1st February 2019) Authors: Delea, Thomas E.; Sharma, Arati; Grossman, Aaron; Eichten, Caitlin; Fenton, Keenan; Josephson, Neil; Richhariya, Akshara; Moskowitz, Alison J. Journal: Journal of medical economics Issue: Volume 22:Number 2(2019) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial. Issue 13 (10th November 2021) Authors: Horwitz, Steven; Zinzani, Pier Luigi; Bagot, Martine; Kim, Youn H.; Moskowitz, Alison J.; Porcu, Pierluigi; Dwyer, Karen; Sun, Wei; Herr, Fiona M.; Scarisbrick, Julia Journal: Leukemia & lymphoma Issue: Volume 62:Issue 13(2021) Page Start: 3109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Moving Beyond One Size Fits All for T-Cell Lymphoma. Issue 3 (20th January 2022) Authors: Moskowitz, Alison J. Journal: Journal of clinical oncology Issue: Volume 40:Issue 3(2022) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mycosis fungoides, Psoriasis and Anti‐PD‐1 – A New Aspect of Known Associations. (14th December 2018) Authors: Geller, Shamir; Pulitzer, Melissa; Horwitz, Steven M.; Moskowitz, Alison J.; Myskowski, Patricia L. Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 17:Number 2(2019) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mycosis fungoides, Psoriasis und PD‐1‐Inhibitoren – neuer Aspekt einer bekannten Assoziation. (14th February 2019) Authors: Geller, Shamir; Pulitzer, Melissa; Horwitz, Steven M.; Moskowitz, Alison J.; Myskowski, Patricia L. Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 17:Number 2(2019) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New frontiers for brentuximab vedotin for lymphomas. Issue 2 (February 2015) Authors: Moskowitz, Alison J. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience. Issue 8 (3rd August 2018) Authors: Giulino-Roth, Lisa; O'Donohue, Tara; Chen, Zhengming; Trippett, Tanya M.; Klein, Elizabeth; Kernan, Nancy A.; Kobos, Rachel; Prockop, Susan E.; Scaradavou, Andromachi; Shukla, Neerav; Steinherz, Peter G.; Moskowitz, Alison J.; Moskowitz, Craig H.; Boulad, Farid Journal: Leukemia & lymphoma Issue: Volume 59:Issue 8(2018) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗